TG Therapeutics Inc (FRA:NKB2)
€ 30.94 -0.06 (-0.19%) Market Cap: 4.69 Bil Enterprise Value: 4.61 Bil PE Ratio: 0 PB Ratio: 24.39 GF Score: 73/100

TG Therapeutics Inc (FRA:NKB2) Transcripts

  • 1